Background: Deinfibulationisasurgicalprocedurecarriedouttore-openthevaginal 
| INTRODUCTION
Type III female genital mutilation (FGM), known as infibulation, is the narrowingofthevaginalorificewithcreationofacoveringsealbycutting andappositioningthelabiaminoraand/orlabiamajora,withorwithout excisionoftheclitoris. andgenital tissue swelling following the infibulation; scarring, keloids, and vaginal obstruction are complications in the longer term. These conditions can lead to reduced quality of life and loss of lifeyears.
2,3
Long-term obstetric complications of FGM include higher risk of prolonged labor, episiotomy, cesarean delivery, postpartum hemorrhage, and prolonged maternal hospitalization. 4 The management of these complicationsmaylikelyfurtherstressthealreadyweakhealthsystems inmanycountriesofSub-SaharanAfricawhereFGMisprevalent.
Thesurgicalcorrectionofinfibulation,alsoreferredtoasanterior episiotomy,iscalleddeinfibulation.Theprocedureconsistsofcutting openthenarrowedvaginalopeninginawomanwhohasbeeninfibulated,whichisoftennecessaryforimprovinghealthandwell-beingas wellastoallowintercourseortofacilitatechildbirth. 
| MATERIALS AND METHODS

13-16
Antenatal deinfibulation was performed at 20-34weeks of gestation. 16 For our second comparison, we included two studies 13, 14 involving 532 participants who had never undergone FGM. These studies compared pregnancy outcomes of women who underwent deinfibulationwiththoseofwomenwhohadneverundergoneFGM.
Theagerangeofparticipantsinthreestudieswas23-38years, [13] [14] [15] andtheywerepredominantlyofAfricanorigin, [13] [14] [15] [16] particularlySomalian.
| Comparison 1: Deinfibulation versus no deinfibulation among women living with type III FGM
Two case-control studies, one with serious risk of bias, involving 503 womenevaluatedobstetricoutcomesinwomenlivingwithtypeIIIFGM withorwithnodeinfibulation. 15, 16 Obstetric outcomes assessed included: 
| Comparison 2: Deinfibulation versus women with no FGM
Twocase-controlstudies, 
Records idenƟfied (13 databases) (n=3726)
Records idenƟfied through database searching (n=3724) Noadverseeventswerereportedintheincludedstudies.
| DISCUSSION
Type III FGM, also referred to as infibulation, may cause a number The included studies involved 250-776 women, and were of moderatesize.Halfofthefourstudiesincludedintheanalysiswere assessed as having "serious" overall risk of bias. The quality of evidencefromthefourstudiesincludedinthisreviewwasverylow.Two (50%) were assessed to be of serious risk of bias in the domains of "selectionofstudyparticipants"and"measurementofintervention"of ROBINS-I.
15,16
Thesetwostudieswerealsoassessedtohaveserious overallriskofbiasandtheycontributeddatatotheeffectiveoutcomes:
cesareandeliveryandpostpartumhemorrhageaftervaginalbirth. 
| Strengths and limitations
| Practice recommendations
TheRoyalCollegeofObstetriciansandGynaecologists(RCOG)andthe
Society of Obstetricians and Gynaecologists of Canada (SOGC) recommend that clinicians examine every woman's external genitalia during medicalconsultationtodocumentthepresenceandtypeofFGM. 18, 19 Physicians are to also ask about gynecologic complications that precedethepregnancyinthoselivingwithtypeIIIFGM.Cliniciansshould be aware on the benefits of deinfibulation and the need to counsel andofferdeinfibulationtowomenlivingwithtypeIIIFGManddecline requests for reinfibulation.
19
The RCOG also recommends that deinfibulationshouldbeperformedonallwomenlivingwithtypeIIIFGM, preferablybeforefirstsexualintercourse. 
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